Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

520 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Publisher Correction: Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease.
Jamialahmadi O, De Vincentis A, Tavaglione F, Malvestiti F, Li-Gao R, Mancina RM, Alvarez M, Gelev K, Maurotti S, Vespasiani-Gentilucci U, Rosendaal FR, Kozlitina J, Pajukanta P, Pattou F, Valenti L, Romeo S. Jamialahmadi O, et al. Among authors: romeo s. Nat Med. 2025 Jan 16. doi: 10.1038/s41591-025-03503-2. Online ahead of print. Nat Med. 2025. PMID: 39820106 No abstract available.
AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: two randomized phase I trials.
Armisen J, Rauschecker M, Sarv J, Liljeblad M, Wernevik L, Niazi M, Knöchel J, Eklund O, Sandell T, Sherwood J, Bergenholm L, Hallén S, Wang S, Kamble P, Bhat M, Maxvall I, Wang Y, Lee RG, Bhanot S, Guo S, Romeo S, Lawitz E, Fjellström O, Lindén D, Blau JE, Loomba R. Armisen J, et al. Among authors: romeo s. J Hepatol. 2025 Jan 9:S0168-8278(25)00003-0. doi: 10.1016/j.jhep.2024.12.046. Online ahead of print. J Hepatol. 2025. PMID: 39798707 Free article.
MARC1 downregulation reduces hepatocyte lipid content by increasing beta-oxidation.
Ciociola E, Dutta T, Sasidharan K, Kovooru L, Noto FR, Pennisi G, Petta S, Mirarchi A, Maurotti S, Scopacasa B, Tirinato L, Candeloro P, Henricsson M, Lindén D, Jamialahmadi O, Pujia A, Mancina RM, Romeo S. Ciociola E, et al. Among authors: romeo s. Clin Mol Hepatol. 2024 Dec 23. doi: 10.3350/cmh.2024.0642. Online ahead of print. Clin Mol Hepatol. 2024. PMID: 39716370 Free article.
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease.
Jamialahmadi O, De Vincentis A, Tavaglione F, Malvestiti F, Li-Gao R, Mancina RM, Alvarez M, Gelev K, Maurotti S, Vespasiani-Gentilucci U, Rosendaal FR, Kozlitina J, Pajukanta P, Pattou F, Valenti L, Romeo S. Jamialahmadi O, et al. Among authors: romeo s. Nat Med. 2024 Dec;30(12):3614-3623. doi: 10.1038/s41591-024-03284-0. Epub 2024 Dec 9. Nat Med. 2024. PMID: 39653778 Free PMC article.
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease.
Raverdy V, Tavaglione F, Chatelain E, Lassailly G, De Vincentis A, Vespasiani-Gentilucci U, Qadri SF, Caiazzo R, Verkindt H, Saponaro C, Kerr-Conte J, Baud G, Marciniak C, Chetboun M, Oukhouya-Daoud N, Blanck S, Vandel J, Olsson L, Chakaroun R, Gnemmi V, Leteurtre E, Lefebvre P, Haas JT, Yki-Järvinen H, Francque S, Staels B, Le Roux CW, Tremaroli V, Mathurin P, Marot G, Romeo S, Pattou F. Raverdy V, et al. Among authors: romeo s. Nat Med. 2024 Dec;30(12):3624-3633. doi: 10.1038/s41591-024-03283-1. Epub 2024 Dec 9. Nat Med. 2024. PMID: 39653777 Free PMC article.
520 results